Microarray Analysis of Gene Expression in Liver Tumors
NCT00373737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2010-07-27
Summary
This study aims to study the gene expression profiles of liver tumors to help us understand their biology, and to find new tumor and treatment markers for liver cancer.
Conditions
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH - lead OTHER
Principal Investigators
-
Samuel So · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-05-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-12-31
Countries
- United States
Study Locations
More Related Trials
-
Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing
NCT03718897 ·Status: UNKNOWN
-
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
NCT00568906 ·Status: TERMINATED
-
Genetic Studies in Liver Cancer Patients
NCT00172640 ·Status: UNKNOWN
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
Genomic Profiling in Cancer Patients
NCT01775072 ·Status: RECRUITING
-
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787 ·Status: TERMINATED
-
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
NCT05880797 ·Status: RECRUITING
-
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
NCT05901376 ·Status: UNKNOWN
-
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00858000 ·Status: COMPLETED
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
NCT03762733 ·Status: ENROLLING_BY_INVITATION
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
NCT02215928 ·Status: RECRUITING
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
NCT02297087 ·Status: TERMINATED ·Phase: NA
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Biomarkers in Young Patients With Neuroblastoma
NCT01169376 ·Status: COMPLETED
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202
NCT00990873 ·Status: COMPLETED
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
NCT00899704 ·Status: WITHDRAWN
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas
NCT05783973 ·Status: UNKNOWN